These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1297109)

  • 21. [Action of propafenon hydrochloride in experimental ventricular arrhythmias induced by barium chloride].
    Germiniani H; Germiniani Cde L
    Arq Bras Cardiol; 1981 Feb; 36(2):101-5. PubMed ID: 7325828
    [No Abstract]   [Full Text] [Related]  

  • 22. 'Early' ischemia and reperfusion-induced arrhythmias: antiarrhythmic effects of diltiazem in the conscious rat.
    Kinoshita K; Hearse DJ; Braimbridge MV; Manning AS
    Can J Cardiol; 1988; 4(1):37-43. PubMed ID: 3359353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antiarrhythmic activity of alaglyzin].
    Bryzgalov AO; Volkova EB; Ganenko IuA; Dolgikh MP; Zhukova NA; Sorokina IV; Tolstikova TG
    Eksp Klin Farmakol; 2005; 68(4):24-7. PubMed ID: 16193652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention of arrhythmia in rats by puhuang].
    Zheng RX; Fang SM; Li ZM; Zhang XM
    Zhongguo Zhong Yao Za Zhi; 1993 Feb; 18(2):108-10, 127. PubMed ID: 8323694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The anti-arrhythmia and pro-arrhythmia properties of sigma-receptor ligands].
    Lishmanov IuB; Maslov LN; Krylatov AV; Ugdyzhekova DS; Gilligan P; Tam SW
    Eksp Klin Farmakol; 2000; 63(2):39-43. PubMed ID: 10834092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chiral 2-amino-1-butanol xanthone derivatives as potential antiarrhythmic and hypotensive agents.
    Librowski T; Czarnecki R; Jastrzebska M
    Acta Pol Pharm; 1999; 56(1):87-90. PubMed ID: 10635353
    [No Abstract]   [Full Text] [Related]  

  • 27. [Some aspects of the antiarrhythmic effect of glialin].
    Khisatmutdinova RIu; Baschenko NZh; Zarudiĭ FS; Gabdrakhmanova SF; Makara NS; Sapozhnikova TA
    Eksp Klin Farmakol; 2006; 69(3):26-8. PubMed ID: 16878494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The anti-arrhythmia action of an extract of Rhodiola rosea and of n-tyrosol in models of experimental arrhythmias].
    Maĭmeskulova LA; Maslov LN
    Eksp Klin Farmakol; 1998; 61(2):37-40. PubMed ID: 9621172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased sensitivity to diltiazem hypotensive effect in an experimental model of high-renin hypertension.
    Bertera FM; Mayer MA; Opezzo JA; Taira CA; Höcht C
    J Pharm Pharmacol; 2009 Jan; 61(1):79-87. PubMed ID: 19126300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nasal administration of the calcium channel blocker diltiazem decreases food intake and attenuates weight gain in rats.
    Amer A; Maher TJ
    Pharmacol Biochem Behav; 2005 Oct; 82(2):379-87. PubMed ID: 16214208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The anti-arrhythmic activity of quinuclidine derivatives].
    Svistov AS; Skorobogatov VI
    Eksp Klin Farmakol; 1994; 57(5):20-1. PubMed ID: 7696896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of naloxone on rhythm disorders and on the conduction system of the heart].
    Shliakhto EV; Zaĭtsev AA; Panov AV; Ardashev AV; Nifontov EM; Kashina EA; Kazarin VV; Ivanov VV
    Eksp Klin Farmakol; 1996; 59(3):34-6. PubMed ID: 8974581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiarrhythmic effect of KB-944, a new calcium antagonist. A comparison with verapamil and diltiazem.
    Yoshidomi M; Sukamoto T; Morita T; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1056-9. PubMed ID: 6890826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiarrhythmic and antihypertensive activity of some xanthone derivatives.
    Marona H; Librowski T; Cegła M; Erdoğan C; Sahin NO
    Acta Pol Pharm; 2008; 65(3):383-90. PubMed ID: 18646559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of lithium hydroxybutyrate and lithium chloride on heart rhythm disorders of various origins].
    Galenko-Iaroshevskiĭ PA; Shadurskiĭ KS; Tikhonov AV
    Farmakol Toksikol; 1984; 47(4):54-9. PubMed ID: 6090202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The polymorphism of the pharmacological effects of calcium channel blockers].
    Ivanova TM; Podosinovikova NP; Dolgo-Saburov VB; Predtechenskiĭ MB; Stepanova NA
    Farmakol Toksikol; 1990; 53(2):34-6. PubMed ID: 2369951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiarrhythmic effect related to the plasma concentration of pentisomide in vivo and the antiarrhythmic-concentration relationship in vitro.
    Hachisu M; Chen H; Soneda T; Fujishima K; Ishizuka T; Konno F
    Drugs Exp Clin Res; 1995; 21(4):145-51. PubMed ID: 8529527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The antiarrhythmic action of the synthetic acetylcholine analog EDIHYP in calcium chloride- and strophanthin-induced heart rhythm disorders].
    Abdikaliev NA; Kalvin'sh IIa; Meerson FZ
    Farmakol Toksikol; 1991; 54(6):25-8. PubMed ID: 1804687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experimental arrhythmia models. Critical study of correlations with arrhythmias observed in clinical practice].
    Dupuis BA; Vincent AC
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():17-27. PubMed ID: 6803699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of diltiazem and nifedipine in some animal models of depression.
    Kostowski W; Dyr W; Puciłowski O
    Pol J Pharmacol Pharm; 1990; 42(2):121-7. PubMed ID: 2274470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.